Trends in medicines procurement by the Brazilian federal government from 2006 to 2013

Open Access

Peer-reviewed

Research Article

Tatiana Chama Borges Luz ,

* E-mail: tatianachama@cpqrr.fiocruz.br

Affiliations René Rachou Research Center/ Oswaldo Cruz Foundation, Belo Horizonte, Minas Gerais, Brazil, Department of Medicine, Clinical Epidemiology, Karolinska Institutet, Stockholm, Sweden
⨯
Claudia Garcia Serpa Osorio-de-Castro,

Affiliation Department of Pharmaceutical Policies and Pharmaceutical Services (NAF), Sergio Arouca National School of Public Health/Oswaldo Cruz Foundation, Rio de Janeiro, Rio de Janeiro, Brazil
⨯
Rachel Magarinos-Torres,

Affiliation School of Pharmacy, Federal Fluminense University, Niterói, Rio de Janeiro, Brazil
⨯
Bjorn Wettermark

Affiliations Department of Medicine, Clinical Epidemiology, Karolinska Institutet, Stockholm, Sweden, Department of Healthcare Development, Public Healthcare Services Committee, Stockholm County Council, Stockholm, Sweden
⨯

Reader Comments (0)

Procurement
Is the Subject Area "Procurement" applicable to this article?

Thanks for your feedback.
Brazil
Is the Subject Area "Brazil" applicable to this article?

Thanks for your feedback.
Drug prices
Is the Subject Area "Drug prices" applicable to this article?

Thanks for your feedback.
Governments
Is the Subject Area "Governments" applicable to this article?

Thanks for your feedback.
Health care policy
Is the Subject Area "Health care policy" applicable to this article?

Thanks for your feedback.
Drug therapy
Is the Subject Area "Drug therapy" applicable to this article?

Thanks for your feedback.
Cardiology
Is the Subject Area "Cardiology" applicable to this article?

Thanks for your feedback.
Monetary policy
Is the Subject Area "Monetary policy" applicable to this article?

Thanks for your feedback.